Through genetic, clinical, and biochemical analyses, we further characterize the phenotypic spectrum of GOT2 deficiency.<h4>Results</h4>Most patients exhibited progressive neurodevelopmental delay, severe to profound intellectual disability, infantile epilepsy, progressive microcephaly, and hypotonia evolving into spasticity with axial hypotonia. The gene discussed is GOT2; the disease is microcephaly.